Imatinib mesylate treatment in a patient with chemoresistant Ph+ acute myeloid leukemia: possible role of Wilms' tumor gene 1.
Quartarone
Eugenia
E
Allegra
Alessandro
A
Alonci
Andrea
A
Toscano
Giuseppe
G
Bellomo
Giacomo
G
Corigliano
Elisabetta
E
Del Fabro
Vittorio
V
Musolino
Caterina
C
D000208:Acute Disease; D000293:Adolescent; D001549:Benzamides; D019008:Drug Resistance, Neoplasm; D005260:Female; D016162:Genes, Wilms Tumor / Q000502:physiology*; D006801:Humans; D000068877:Imatinib Mesylate; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy* / Q000209:etiology*; D010879:Piperazines / Q000627:therapeutic use*; D011743:Pyrimidines / Q000627:therapeutic use*
D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate